nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—Jaundice—Docetaxel—stomach cancer	0.00218	0.00218	CcSEcCtD
Ceftazidime—Leukopenia—Fluorouracil—stomach cancer	0.00217	0.00217	CcSEcCtD
Ceftazidime—Infestation NOS—Capecitabine—stomach cancer	0.00216	0.00216	CcSEcCtD
Ceftazidime—Infestation—Capecitabine—stomach cancer	0.00216	0.00216	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.00214	0.00214	CcSEcCtD
Ceftazidime—Lethargy—Methotrexate—stomach cancer	0.00213	0.00213	CcSEcCtD
Ceftazidime—Renal failure—Capecitabine—stomach cancer	0.00213	0.00213	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Docetaxel—stomach cancer	0.00211	0.00211	CcSEcCtD
Ceftazidime—Jaundice—Capecitabine—stomach cancer	0.00211	0.00211	CcSEcCtD
Ceftazidime—Phlebitis—Doxorubicin—stomach cancer	0.0021	0.0021	CcSEcCtD
Ceftazidime—Convulsion—Fluorouracil—stomach cancer	0.0021	0.0021	CcSEcCtD
Ceftazidime—Hot flush—Epirubicin—stomach cancer	0.00209	0.00209	CcSEcCtD
Ceftazidime—Thrombophlebitis—Doxorubicin—stomach cancer	0.00209	0.00209	CcSEcCtD
Ceftazidime—Agranulocytosis—Docetaxel—stomach cancer	0.00209	0.00209	CcSEcCtD
Ceftazidime—Menopausal symptoms—Epirubicin—stomach cancer	0.00207	0.00207	CcSEcCtD
Ceftazidime—Hepatic function abnormal—Doxorubicin—stomach cancer	0.00207	0.00207	CcSEcCtD
Ceftazidime—Anaphylactic shock—Irinotecan—stomach cancer	0.00206	0.00206	CcSEcCtD
Ceftazidime—Renal impairment—Epirubicin—stomach cancer	0.00205	0.00205	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Capecitabine—stomach cancer	0.00205	0.00205	CcSEcCtD
Ceftazidime—Nervous system disorder—Irinotecan—stomach cancer	0.00202	0.00202	CcSEcCtD
Ceftazidime—Agranulocytosis—Capecitabine—stomach cancer	0.00202	0.00202	CcSEcCtD
Ceftazidime—Thrombocytopenia—Irinotecan—stomach cancer	0.00202	0.00202	CcSEcCtD
Ceftazidime—Haemoglobin—Docetaxel—stomach cancer	0.00202	0.00202	CcSEcCtD
Ceftazidime—Haemorrhage—Docetaxel—stomach cancer	0.00201	0.00201	CcSEcCtD
Ceftazidime—Lethargy—Epirubicin—stomach cancer	0.002	0.002	CcSEcCtD
Ceftazidime—Anaphylactic shock—Fluorouracil—stomach cancer	0.00197	0.00197	CcSEcCtD
Ceftazidime—Haemoglobin—Capecitabine—stomach cancer	0.00195	0.00195	CcSEcCtD
Ceftazidime—Haemorrhage—Capecitabine—stomach cancer	0.00194	0.00194	CcSEcCtD
Ceftazidime—Nervous system disorder—Fluorouracil—stomach cancer	0.00194	0.00194	CcSEcCtD
Ceftazidime—Hot flush—Doxorubicin—stomach cancer	0.00193	0.00193	CcSEcCtD
Ceftazidime—Thrombocytopenia—Fluorouracil—stomach cancer	0.00193	0.00193	CcSEcCtD
Ceftazidime—Hypotension—Irinotecan—stomach cancer	0.00193	0.00193	CcSEcCtD
Ceftazidime—Menopausal symptoms—Doxorubicin—stomach cancer	0.00192	0.00192	CcSEcCtD
Ceftazidime—Renal impairment—Doxorubicin—stomach cancer	0.0019	0.0019	CcSEcCtD
Ceftazidime—Erythema multiforme—Docetaxel—stomach cancer	0.0019	0.0019	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.00188	0.00188	CcSEcCtD
Ceftazidime—Flushing—Docetaxel—stomach cancer	0.00186	0.00186	CcSEcCtD
Ceftazidime—Paraesthesia—Irinotecan—stomach cancer	0.00185	0.00185	CcSEcCtD
Ceftazidime—Lethargy—Doxorubicin—stomach cancer	0.00185	0.00185	CcSEcCtD
Ceftazidime—Hypotension—Fluorouracil—stomach cancer	0.00184	0.00184	CcSEcCtD
Ceftazidime—Erythema multiforme—Capecitabine—stomach cancer	0.00184	0.00184	CcSEcCtD
Ceftazidime—Angiopathy—Docetaxel—stomach cancer	0.00182	0.00182	CcSEcCtD
Ceftazidime—Immune system disorder—Docetaxel—stomach cancer	0.00181	0.00181	CcSEcCtD
Ceftazidime—Flushing—Capecitabine—stomach cancer	0.0018	0.0018	CcSEcCtD
Ceftazidime—Eosinophilia—Methotrexate—stomach cancer	0.00179	0.00179	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00178	0.00178	CcSEcCtD
Ceftazidime—Paraesthesia—Fluorouracil—stomach cancer	0.00177	0.00177	CcSEcCtD
Ceftazidime—Pain—Irinotecan—stomach cancer	0.00176	0.00176	CcSEcCtD
Ceftazidime—Angiopathy—Capecitabine—stomach cancer	0.00176	0.00176	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.00176	0.00176	CcSEcCtD
Ceftazidime—Immune system disorder—Capecitabine—stomach cancer	0.00175	0.00175	CcSEcCtD
Ceftazidime—Pancytopenia—Methotrexate—stomach cancer	0.00172	0.00172	CcSEcCtD
Ceftazidime—Dysgeusia—Docetaxel—stomach cancer	0.00171	0.00171	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.0017	0.0017	CcSEcCtD
Ceftazidime—Neutropenia—Methotrexate—stomach cancer	0.00169	0.00169	CcSEcCtD
Ceftazidime—Pain—Fluorouracil—stomach cancer	0.00169	0.00169	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Irinotecan—stomach cancer	0.00169	0.00169	CcSEcCtD
Ceftazidime—Eosinophilia—Epirubicin—stomach cancer	0.00167	0.00167	CcSEcCtD
Ceftazidime—Dysgeusia—Capecitabine—stomach cancer	0.00166	0.00166	CcSEcCtD
Ceftazidime—Body temperature increased—Irinotecan—stomach cancer	0.00163	0.00163	CcSEcCtD
Ceftazidime—Abdominal pain—Irinotecan—stomach cancer	0.00163	0.00163	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.00163	0.00163	CcSEcCtD
Ceftazidime—Infestation NOS—Methotrexate—stomach cancer	0.00161	0.00161	CcSEcCtD
Ceftazidime—Infestation—Methotrexate—stomach cancer	0.00161	0.00161	CcSEcCtD
Ceftazidime—Pancytopenia—Epirubicin—stomach cancer	0.00161	0.00161	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.0016	0.0016	CcSEcCtD
Ceftazidime—Vision blurred—Capecitabine—stomach cancer	0.00159	0.00159	CcSEcCtD
Ceftazidime—Tremor—Capecitabine—stomach cancer	0.00158	0.00158	CcSEcCtD
Ceftazidime—Renal failure—Methotrexate—stomach cancer	0.00158	0.00158	CcSEcCtD
Ceftazidime—Neutropenia—Epirubicin—stomach cancer	0.00158	0.00158	CcSEcCtD
Ceftazidime—Urticaria—Fluorouracil—stomach cancer	0.00157	0.00157	CcSEcCtD
Ceftazidime—Leukopenia—Docetaxel—stomach cancer	0.00156	0.00156	CcSEcCtD
Ceftazidime—Body temperature increased—Fluorouracil—stomach cancer	0.00156	0.00156	CcSEcCtD
Ceftazidime—Eosinophilia—Doxorubicin—stomach cancer	0.00155	0.00155	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Methotrexate—stomach cancer	0.00152	0.00152	CcSEcCtD
Ceftazidime—Hypersensitivity—Irinotecan—stomach cancer	0.00152	0.00152	CcSEcCtD
Ceftazidime—Leukopenia—Capecitabine—stomach cancer	0.00151	0.00151	CcSEcCtD
Ceftazidime—Convulsion—Docetaxel—stomach cancer	0.00151	0.00151	CcSEcCtD
Ceftazidime—Infestation NOS—Epirubicin—stomach cancer	0.00151	0.00151	CcSEcCtD
Ceftazidime—Infestation—Epirubicin—stomach cancer	0.00151	0.00151	CcSEcCtD
Ceftazidime—Agranulocytosis—Methotrexate—stomach cancer	0.0015	0.0015	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.00149	0.00149	CcSEcCtD
Ceftazidime—Pancytopenia—Doxorubicin—stomach cancer	0.00149	0.00149	CcSEcCtD
Ceftazidime—Renal failure—Epirubicin—stomach cancer	0.00148	0.00148	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00148	0.00148	CcSEcCtD
Ceftazidime—Jaundice—Epirubicin—stomach cancer	0.00147	0.00147	CcSEcCtD
Ceftazidime—Neutropenia—Doxorubicin—stomach cancer	0.00146	0.00146	CcSEcCtD
Ceftazidime—Hypersensitivity—Fluorouracil—stomach cancer	0.00145	0.00145	CcSEcCtD
Ceftazidime—Haemoglobin—Methotrexate—stomach cancer	0.00145	0.00145	CcSEcCtD
Ceftazidime—Haemorrhage—Methotrexate—stomach cancer	0.00145	0.00145	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00143	0.00143	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Epirubicin—stomach cancer	0.00143	0.00143	CcSEcCtD
Ceftazidime—Anaphylactic shock—Docetaxel—stomach cancer	0.00142	0.00142	CcSEcCtD
Ceftazidime—Diarrhoea—Irinotecan—stomach cancer	0.00141	0.00141	CcSEcCtD
Ceftazidime—Agranulocytosis—Epirubicin—stomach cancer	0.00141	0.00141	CcSEcCtD
Ceftazidime—Nervous system disorder—Docetaxel—stomach cancer	0.0014	0.0014	CcSEcCtD
Ceftazidime—Pruritus—Fluorouracil—stomach cancer	0.0014	0.0014	CcSEcCtD
Ceftazidime—Thrombocytopenia—Docetaxel—stomach cancer	0.0014	0.0014	CcSEcCtD
Ceftazidime—Infestation NOS—Doxorubicin—stomach cancer	0.00139	0.00139	CcSEcCtD
Ceftazidime—Infestation—Doxorubicin—stomach cancer	0.00139	0.00139	CcSEcCtD
Ceftazidime—Skin disorder—Docetaxel—stomach cancer	0.00138	0.00138	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00138	0.00138	CcSEcCtD
Ceftazidime—Renal failure—Doxorubicin—stomach cancer	0.00137	0.00137	CcSEcCtD
Ceftazidime—Erythema multiforme—Methotrexate—stomach cancer	0.00137	0.00137	CcSEcCtD
Ceftazidime—Dizziness—Irinotecan—stomach cancer	0.00136	0.00136	CcSEcCtD
Ceftazidime—Haemoglobin—Epirubicin—stomach cancer	0.00136	0.00136	CcSEcCtD
Ceftazidime—Jaundice—Doxorubicin—stomach cancer	0.00136	0.00136	CcSEcCtD
Ceftazidime—Nervous system disorder—Capecitabine—stomach cancer	0.00135	0.00135	CcSEcCtD
Ceftazidime—Haemorrhage—Epirubicin—stomach cancer	0.00135	0.00135	CcSEcCtD
Ceftazidime—Diarrhoea—Fluorouracil—stomach cancer	0.00135	0.00135	CcSEcCtD
Ceftazidime—Thrombocytopenia—Capecitabine—stomach cancer	0.00135	0.00135	CcSEcCtD
Ceftazidime—Skin disorder—Capecitabine—stomach cancer	0.00134	0.00134	CcSEcCtD
Ceftazidime—Hypotension—Docetaxel—stomach cancer	0.00133	0.00133	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00132	0.00132	CcSEcCtD
Ceftazidime—Angiopathy—Methotrexate—stomach cancer	0.00131	0.00131	CcSEcCtD
Ceftazidime—Vomiting—Irinotecan—stomach cancer	0.00131	0.00131	CcSEcCtD
Ceftazidime—Immune system disorder—Methotrexate—stomach cancer	0.00131	0.00131	CcSEcCtD
Ceftazidime—Dizziness—Fluorouracil—stomach cancer	0.00131	0.00131	CcSEcCtD
Ceftazidime—Agranulocytosis—Doxorubicin—stomach cancer	0.0013	0.0013	CcSEcCtD
Ceftazidime—Rash—Irinotecan—stomach cancer	0.0013	0.0013	CcSEcCtD
Ceftazidime—Dermatitis—Irinotecan—stomach cancer	0.0013	0.0013	CcSEcCtD
Ceftazidime—Headache—Irinotecan—stomach cancer	0.00129	0.00129	CcSEcCtD
Ceftazidime—Hypotension—Capecitabine—stomach cancer	0.00129	0.00129	CcSEcCtD
Ceftazidime—Paraesthesia—Docetaxel—stomach cancer	0.00128	0.00128	CcSEcCtD
Ceftazidime—Erythema multiforme—Epirubicin—stomach cancer	0.00128	0.00128	CcSEcCtD
Ceftazidime—Haemoglobin—Doxorubicin—stomach cancer	0.00126	0.00126	CcSEcCtD
Ceftazidime—Flushing—Epirubicin—stomach cancer	0.00126	0.00126	CcSEcCtD
Ceftazidime—Vomiting—Fluorouracil—stomach cancer	0.00126	0.00126	CcSEcCtD
Ceftazidime—Haemorrhage—Doxorubicin—stomach cancer	0.00125	0.00125	CcSEcCtD
Ceftazidime—Rash—Fluorouracil—stomach cancer	0.00124	0.00124	CcSEcCtD
Ceftazidime—Dermatitis—Fluorouracil—stomach cancer	0.00124	0.00124	CcSEcCtD
Ceftazidime—Paraesthesia—Capecitabine—stomach cancer	0.00124	0.00124	CcSEcCtD
Ceftazidime—Headache—Fluorouracil—stomach cancer	0.00124	0.00124	CcSEcCtD
Ceftazidime—Dysgeusia—Methotrexate—stomach cancer	0.00123	0.00123	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00123	0.00123	CcSEcCtD
Ceftazidime—Angiopathy—Epirubicin—stomach cancer	0.00123	0.00123	CcSEcCtD
Ceftazidime—Nausea—Irinotecan—stomach cancer	0.00122	0.00122	CcSEcCtD
Ceftazidime—Immune system disorder—Epirubicin—stomach cancer	0.00122	0.00122	CcSEcCtD
Ceftazidime—Pain—Docetaxel—stomach cancer	0.00122	0.00122	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00119	0.00119	CcSEcCtD
Ceftazidime—Vision blurred—Methotrexate—stomach cancer	0.00119	0.00119	CcSEcCtD
Ceftazidime—Erythema multiforme—Doxorubicin—stomach cancer	0.00118	0.00118	CcSEcCtD
Ceftazidime—Pain—Capecitabine—stomach cancer	0.00118	0.00118	CcSEcCtD
Ceftazidime—Nausea—Fluorouracil—stomach cancer	0.00117	0.00117	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Docetaxel—stomach cancer	0.00117	0.00117	CcSEcCtD
Ceftazidime—Flushing—Doxorubicin—stomach cancer	0.00116	0.00116	CcSEcCtD
Ceftazidime—Dysgeusia—Epirubicin—stomach cancer	0.00115	0.00115	CcSEcCtD
Ceftazidime—Angiopathy—Doxorubicin—stomach cancer	0.00114	0.00114	CcSEcCtD
Ceftazidime—Immune system disorder—Doxorubicin—stomach cancer	0.00113	0.00113	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Capecitabine—stomach cancer	0.00113	0.00113	CcSEcCtD
Ceftazidime—Body temperature increased—Docetaxel—stomach cancer	0.00113	0.00113	CcSEcCtD
Ceftazidime—Abdominal pain—Docetaxel—stomach cancer	0.00113	0.00113	CcSEcCtD
Ceftazidime—Leukopenia—Methotrexate—stomach cancer	0.00113	0.00113	CcSEcCtD
Ceftazidime—Vision blurred—Epirubicin—stomach cancer	0.00111	0.00111	CcSEcCtD
Ceftazidime—Urticaria—Capecitabine—stomach cancer	0.0011	0.0011	CcSEcCtD
Ceftazidime—Body temperature increased—Capecitabine—stomach cancer	0.00109	0.00109	CcSEcCtD
Ceftazidime—Abdominal pain—Capecitabine—stomach cancer	0.00109	0.00109	CcSEcCtD
Ceftazidime—Convulsion—Methotrexate—stomach cancer	0.00109	0.00109	CcSEcCtD
Ceftazidime—Agitation—Epirubicin—stomach cancer	0.00108	0.00108	CcSEcCtD
Ceftazidime—Dysgeusia—Doxorubicin—stomach cancer	0.00107	0.00107	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00106	0.00106	CcSEcCtD
Ceftazidime—Leukopenia—Epirubicin—stomach cancer	0.00105	0.00105	CcSEcCtD
Ceftazidime—Hypersensitivity—Docetaxel—stomach cancer	0.00105	0.00105	CcSEcCtD
Ceftazidime—Anaphylactic shock—Methotrexate—stomach cancer	0.00103	0.00103	CcSEcCtD
Ceftazidime—Vision blurred—Doxorubicin—stomach cancer	0.00103	0.00103	CcSEcCtD
Ceftazidime—Convulsion—Epirubicin—stomach cancer	0.00102	0.00102	CcSEcCtD
Ceftazidime—Hypersensitivity—Capecitabine—stomach cancer	0.00102	0.00102	CcSEcCtD
Ceftazidime—Pruritus—Docetaxel—stomach cancer	0.00101	0.00101	CcSEcCtD
Ceftazidime—Nervous system disorder—Methotrexate—stomach cancer	0.00101	0.00101	CcSEcCtD
Ceftazidime—Thrombocytopenia—Methotrexate—stomach cancer	0.00101	0.00101	CcSEcCtD
Ceftazidime—Agitation—Doxorubicin—stomach cancer	0.001	0.001	CcSEcCtD
Ceftazidime—Skin disorder—Methotrexate—stomach cancer	0.000998	0.000998	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000996	0.000996	CcSEcCtD
Ceftazidime—Pruritus—Capecitabine—stomach cancer	0.000976	0.000976	CcSEcCtD
Ceftazidime—Leukopenia—Doxorubicin—stomach cancer	0.000975	0.000975	CcSEcCtD
Ceftazidime—Diarrhoea—Docetaxel—stomach cancer	0.000975	0.000975	CcSEcCtD
Ceftazidime—Anaphylactic shock—Epirubicin—stomach cancer	0.000961	0.000961	CcSEcCtD
Ceftazidime—Hypotension—Methotrexate—stomach cancer	0.00096	0.00096	CcSEcCtD
Ceftazidime—Convulsion—Doxorubicin—stomach cancer	0.000944	0.000944	CcSEcCtD
Ceftazidime—Diarrhoea—Capecitabine—stomach cancer	0.000944	0.000944	CcSEcCtD
Ceftazidime—Nervous system disorder—Epirubicin—stomach cancer	0.000943	0.000943	CcSEcCtD
Ceftazidime—Dizziness—Docetaxel—stomach cancer	0.000942	0.000942	CcSEcCtD
Ceftazidime—Thrombocytopenia—Epirubicin—stomach cancer	0.000941	0.000941	CcSEcCtD
Ceftazidime—Skin disorder—Epirubicin—stomach cancer	0.000934	0.000934	CcSEcCtD
Ceftazidime—Paraesthesia—Methotrexate—stomach cancer	0.000922	0.000922	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000921	0.000921	CcSEcCtD
Ceftazidime—Dizziness—Capecitabine—stomach cancer	0.000912	0.000912	CcSEcCtD
Ceftazidime—Vomiting—Docetaxel—stomach cancer	0.000906	0.000906	CcSEcCtD
Ceftazidime—Rash—Docetaxel—stomach cancer	0.000898	0.000898	CcSEcCtD
Ceftazidime—Hypotension—Epirubicin—stomach cancer	0.000898	0.000898	CcSEcCtD
Ceftazidime—Dermatitis—Docetaxel—stomach cancer	0.000898	0.000898	CcSEcCtD
Ceftazidime—Headache—Docetaxel—stomach cancer	0.000893	0.000893	CcSEcCtD
Ceftazidime—Anaphylactic shock—Doxorubicin—stomach cancer	0.000889	0.000889	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000887	0.000887	CcSEcCtD
Ceftazidime—Pain—Methotrexate—stomach cancer	0.000878	0.000878	CcSEcCtD
Ceftazidime—Vomiting—Capecitabine—stomach cancer	0.000877	0.000877	CcSEcCtD
Ceftazidime—Nervous system disorder—Doxorubicin—stomach cancer	0.000872	0.000872	CcSEcCtD
Ceftazidime—Thrombocytopenia—Doxorubicin—stomach cancer	0.000871	0.000871	CcSEcCtD
Ceftazidime—Rash—Capecitabine—stomach cancer	0.00087	0.00087	CcSEcCtD
Ceftazidime—Dermatitis—Capecitabine—stomach cancer	0.000869	0.000869	CcSEcCtD
Ceftazidime—Headache—Capecitabine—stomach cancer	0.000864	0.000864	CcSEcCtD
Ceftazidime—Skin disorder—Doxorubicin—stomach cancer	0.000864	0.000864	CcSEcCtD
Ceftazidime—Paraesthesia—Epirubicin—stomach cancer	0.000863	0.000863	CcSEcCtD
Ceftazidime—Nausea—Docetaxel—stomach cancer	0.000846	0.000846	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Methotrexate—stomach cancer	0.00084	0.00084	CcSEcCtD
Ceftazidime—Hypotension—Doxorubicin—stomach cancer	0.000831	0.000831	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00083	0.00083	CcSEcCtD
Ceftazidime—Pain—Epirubicin—stomach cancer	0.000822	0.000822	CcSEcCtD
Ceftazidime—Nausea—Capecitabine—stomach cancer	0.000819	0.000819	CcSEcCtD
Ceftazidime—Urticaria—Methotrexate—stomach cancer	0.000816	0.000816	CcSEcCtD
Ceftazidime—Abdominal pain—Methotrexate—stomach cancer	0.000812	0.000812	CcSEcCtD
Ceftazidime—Body temperature increased—Methotrexate—stomach cancer	0.000812	0.000812	CcSEcCtD
Ceftazidime—Paraesthesia—Doxorubicin—stomach cancer	0.000799	0.000799	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Epirubicin—stomach cancer	0.000786	0.000786	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000768	0.000768	CcSEcCtD
Ceftazidime—Urticaria—Epirubicin—stomach cancer	0.000764	0.000764	CcSEcCtD
Ceftazidime—Pain—Doxorubicin—stomach cancer	0.000761	0.000761	CcSEcCtD
Ceftazidime—Abdominal pain—Epirubicin—stomach cancer	0.00076	0.00076	CcSEcCtD
Ceftazidime—Body temperature increased—Epirubicin—stomach cancer	0.00076	0.00076	CcSEcCtD
Ceftazidime—Hypersensitivity—Methotrexate—stomach cancer	0.000757	0.000757	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000727	0.000727	CcSEcCtD
Ceftazidime—Pruritus—Methotrexate—stomach cancer	0.000727	0.000727	CcSEcCtD
Ceftazidime—Hypersensitivity—Epirubicin—stomach cancer	0.000708	0.000708	CcSEcCtD
Ceftazidime—Urticaria—Doxorubicin—stomach cancer	0.000706	0.000706	CcSEcCtD
Ceftazidime—Abdominal pain—Doxorubicin—stomach cancer	0.000703	0.000703	CcSEcCtD
Ceftazidime—Body temperature increased—Doxorubicin—stomach cancer	0.000703	0.000703	CcSEcCtD
Ceftazidime—Diarrhoea—Methotrexate—stomach cancer	0.000703	0.000703	CcSEcCtD
Ceftazidime—Pruritus—Epirubicin—stomach cancer	0.00068	0.00068	CcSEcCtD
Ceftazidime—Dizziness—Methotrexate—stomach cancer	0.000679	0.000679	CcSEcCtD
Ceftazidime—Diarrhoea—Epirubicin—stomach cancer	0.000658	0.000658	CcSEcCtD
Ceftazidime—Hypersensitivity—Doxorubicin—stomach cancer	0.000655	0.000655	CcSEcCtD
Ceftazidime—Vomiting—Methotrexate—stomach cancer	0.000653	0.000653	CcSEcCtD
Ceftazidime—Rash—Methotrexate—stomach cancer	0.000648	0.000648	CcSEcCtD
Ceftazidime—Dermatitis—Methotrexate—stomach cancer	0.000647	0.000647	CcSEcCtD
Ceftazidime—Headache—Methotrexate—stomach cancer	0.000643	0.000643	CcSEcCtD
Ceftazidime—Dizziness—Epirubicin—stomach cancer	0.000636	0.000636	CcSEcCtD
Ceftazidime—Pruritus—Doxorubicin—stomach cancer	0.000629	0.000629	CcSEcCtD
Ceftazidime—Vomiting—Epirubicin—stomach cancer	0.000611	0.000611	CcSEcCtD
Ceftazidime—Nausea—Methotrexate—stomach cancer	0.00061	0.00061	CcSEcCtD
Ceftazidime—Diarrhoea—Doxorubicin—stomach cancer	0.000608	0.000608	CcSEcCtD
Ceftazidime—Rash—Epirubicin—stomach cancer	0.000606	0.000606	CcSEcCtD
Ceftazidime—Dermatitis—Epirubicin—stomach cancer	0.000605	0.000605	CcSEcCtD
Ceftazidime—Headache—Epirubicin—stomach cancer	0.000602	0.000602	CcSEcCtD
Ceftazidime—Dizziness—Doxorubicin—stomach cancer	0.000588	0.000588	CcSEcCtD
Ceftazidime—Nausea—Epirubicin—stomach cancer	0.000571	0.000571	CcSEcCtD
Ceftazidime—Vomiting—Doxorubicin—stomach cancer	0.000565	0.000565	CcSEcCtD
Ceftazidime—Rash—Doxorubicin—stomach cancer	0.000561	0.000561	CcSEcCtD
Ceftazidime—Dermatitis—Doxorubicin—stomach cancer	0.00056	0.00056	CcSEcCtD
Ceftazidime—Headache—Doxorubicin—stomach cancer	0.000557	0.000557	CcSEcCtD
Ceftazidime—Nausea—Doxorubicin—stomach cancer	0.000528	0.000528	CcSEcCtD
